{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:03:30Z","timestamp":1794330210704,"version":"4.9.0"},"reference-count":84,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Cain Foundation for Infectious Disease Research"},{"name":"University of Texas Health Science Center at Tyler, Texas, United States"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The IL-1 family of cytokines produced by antigen-presenting cells plays important roles in various diseases and infections, including Mycobacterium tuberculosis (Mtb) infection. In the present study, we infected human monocyte-derived macrophages (MDMs) with Mtb. Then, we measured the production of IL-1 superfamily (ILSF) cytokines (8 soluble factors) and determined the effects of ILSF cytokines on Mtb growth via the use of recombinant cytokines and antibodies. Mtb infection significantly increased the production of IL-1\u03b1, IL-1\u03b2, IL-18, and IL-37 and reduced the production of IL-1Ra by MDMs. Human recombinant IL-1\u03b1, IL-1\u03b2, and IL-18 reduced Mtb growth in MDMs. In contrast, human recombinant IL-1Ra enhanced Mtb growth in MDMs. Neutralizing antibodies against IL-1\u03b1, IL-1\u03b2, and IL-18 enhanced Mtb growth, and neutralizing antibodies against IL-1Ra and IL-33R reduced Mtb growth in MDMs. B cells are known to regulate inflammation in tuberculosis (TB) granulomas. We also determined the effects of B and NK cells on ILSF cytokine production by human monocytes. Furthermore, we determined the effect of B cells on Mtb growth in human monocytes. B cells significantly reduced IL-1\u03b1, IL-1\u03b2, IL-6, and TNF-\u03b1 production; enhanced IL-1Ra, IL-18, and IL-10 production; and inhibited Mtb growth in human CD14+ monocytes. These findings may be relevant in human TB granulomas, where B cells may regulate the balance of proinflammatory and anti-inflammatory ILSF cytokines and inhibit TB growth.<\/jats:p>","DOI":"10.1093\/immhor\/vlaf046","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T04:52:42Z","timestamp":1762750362000},"source":"Crossref","is-referenced-by-count":1,"title":["B cells inhibit IL-1 family cytokine production and\n                    <i>Mycobacterium tuberculosis<\/i>\n                    growth in human CD14+ cells"],"prefix":"10.1093","volume":"9","author":[{"given":"Abhinav","family":"Vankayalapati","sequence":"first","affiliation":[{"name":"Center for Biomedical Research, The University of Texas Health Science Center at Tyler , Tyler, TX,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4714-9772","authenticated-orcid":false,"given":"Bharath","family":"Somasundram","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Allergy and Immunology, Saint Louis University , Saint Louis, MO,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padmaja","family":"Paidipally","sequence":"additional","affiliation":[{"name":"Center for Biomedical Research, The University of Texas Health Science Center at Tyler , Tyler, TX,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karan P","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Medicine, The University of Texas Health Science Center at Tyler , Tyler, TX,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramakrishna","family":"Vankayalapati","sequence":"additional","affiliation":[{"name":"Center for Biomedical Research, The University of Texas Health Science Center at Tyler , Tyler, TX,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4664-287X","authenticated-orcid":false,"given":"Rajesh Kumar","family":"Radhakrishnan","sequence":"additional","affiliation":[{"name":"Center for Biomedical Research, The University of Texas Health Science Center at Tyler , Tyler, TX,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"2025111000471264000_vlaf046-B1","author":"Global tuberculosis report 2023. Geneva: World Health Organization; 2023."},{"key":"2025111000471264000_vlaf046-B2","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s41579-022-00763-4","article-title":"Immune evasion and provocation by Mycobacterium tuberculosis","volume":"20","author":"Chandra","year":"2022","journal-title":"Nat Rev Microbiol"},{"key":"2025111000471264000_vlaf046-B3","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/s42003-025-08337-9","article-title":"Human alveolar macrophage response to Mycobacterium tuberculosis: immune characteristics underlying large inter-individual variability","volume":"8","author":"Sadee","year":"2025","journal-title":"Commun Biol"},{"key":"2025111000471264000_vlaf046-B4","doi-asserted-by":"crossref","first-page":"897193","DOI":"10.3389\/fimmu.2022.897193","article-title":"Tuberculosis alters immune-metabolic pathways resulting in perturbed IL-1 responses","volume":"13","author":"Llibre","year":"2022","journal-title":"Front Immunol"},{"key":"2025111000471264000_vlaf046-B5","doi-asserted-by":"crossref","first-page":"776913","DOI":"10.3389\/fimmu.2021.776913","article-title":"Dynamics of macrophage, T and B cell infiltration within pulmonary granulomas induced by Mycobacterium tuberculosis in two non-human primate models of aerosol infection","volume":"12","author":"Hunter","year":"2022","journal-title":"Front Immunol"},{"key":"2025111000471264000_vlaf046-B6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-065X.2007.00545.x","article-title":"Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter?","volume":"219","author":"Berrington","year":"2007","journal-title":"Immunol Rev"},{"key":"2025111000471264000_vlaf046-B7","doi-asserted-by":"crossref","first-page":"e0313421","DOI":"10.1128\/mBio.03134-21","article-title":"Advances on the role and applications of interleukin-1 in tuberculosis","volume":"12","author":"Silv\u00e9rio","year":"2021","journal-title":"mBio"},{"key":"2025111000471264000_vlaf046-B8","doi-asserted-by":"crossref","first-page":"621931","DOI":"10.3389\/fimmu.2020.621931","article-title":"Interleukin-1 as innate mediator of T cell immunity","volume":"11","author":"Van Den Eeckhout","year":"2021","journal-title":"Front Immunol"},{"key":"2025111000471264000_vlaf046-B9","doi-asserted-by":"crossref","first-page":"155890","DOI":"10.1016\/j.cyto.2022.155890","article-title":"The IL-1 cytokine family as custodians of barrier immunity","volume":"154","author":"Matarazzo","year":"2022","journal-title":"Cytokine"},{"key":"2025111000471264000_vlaf046-B10","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1084\/jem.187.9.1463","article-title":"Production of mice deficient in genes for interleukin (IL)-1\u03b1, IL-1\u03b2, IL-1\u03b1\/\u03b2, and IL-1 receptor antagonist shows that IL-1\u03b2 is crucial in turpentine-induced fever development and glucocorticoid secretion","volume":"187","author":"Horai","year":"1998","journal-title":"J Exp Med"},{"key":"2025111000471264000_vlaf046-B11","article-title":"Cytokines and chemokines in Mycobacterium tuberculosis infection","author":"Domingo-Gonzalez"},{"key":"2025111000471264000_vlaf046-B12","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.vaccine.2010.10.045","article-title":"Blocking IL-1\u03b1 but not IL-1\u03b2 increases susceptibility to chronic Mycobacterium tuberculosis infection in mice","volume":"29","author":"Guler","year":"2011","journal-title":"Vaccine"},{"key":"2025111000471264000_vlaf046-B13","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1164\/ajrccm.157.4.9709126","article-title":"Tumor necrosis factor and interleukin-1 inhibitors as markers of disease activity of tuberculosis","volume":"157","author":"Juffermans","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"2025111000471264000_vlaf046-B14","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1038\/s41564-019-0578-3","article-title":"Type I interferon-driven susceptibility to Mycobacterium tuberculosis is mediated by IL-1Ra","volume":"4","author":"Ji","year":"2019","journal-title":"Nat Microbiol"},{"key":"2025111000471264000_vlaf046-B15","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1146\/annurev-immunol-093019-010426","article-title":"The innate immune response to Mycobacterium tuberculosis infection","volume":"39","author":"Ravesloot-Ch\u00e1vez","year":"2021","journal-title":"Annu Rev Immunol"},{"key":"2025111000471264000_vlaf046-B16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/imr.12621","article-title":"Overview of the IL-1 family in innate inflammation and acquired immunity","volume":"281","author":"Dinarello","year":"2018","journal-title":"Immunol Rev"},{"key":"2025111000471264000_vlaf046-B17","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1086\/315656","article-title":"Production of interleukin-18 in human tuberculosis","volume":"182","author":"Vankayalapati","year":"2000","journal-title":"J Infect Dis"},{"key":"2025111000471264000_vlaf046-B18","doi-asserted-by":"crossref","first-page":"6749","DOI":"10.4049\/jimmunol.166.11.6749","article-title":"T cells enhance production of IL-18 by monocytes in response to an intracellular pathogen","volume":"166","author":"Vankayalapati","year":"2001","journal-title":"J Immunol"},{"key":"2025111000471264000_vlaf046-B19","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/s41467-022-28506-2","article-title":"Early alveolar macrophage response and IL-1R-dependent T cell priming determine transmissibility of Mycobacterium tuberculosis strains","volume":"13","author":"Lovey","year":"2022","journal-title":"Nat Commun"},{"key":"2025111000471264000_vlaf046-B20","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.immuni.2011.12.002","article-title":"Innate and adaptive interferons suppress IL-1\u03b1 and IL-1\u03b2 production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection","volume":"35","author":"Mayer-Barber","year":"2011","journal-title":"Immunity"},{"key":"2025111000471264000_vlaf046-B21","doi-asserted-by":"crossref","first-page":"e1011187","DOI":"10.1371\/journal.ppat.1011187","article-title":"B cells promote granulomatous inflammation during chronic Mycobacterium tuberculosis infection in mice","volume":"19","author":"Chen","year":"2023","journal-title":"PLoS Pathog"},{"key":"2025111000471264000_vlaf046-B22","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3390\/vaccines11050955","article-title":"Role of B cells in Mycobacterium tuberculosis infection","volume":"11","author":"Stewart","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"2025111000471264000_vlaf046-B23","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1093\/cid\/civ614","article-title":"B in TB: B cells as mediators of clinically relevant immune responses in tuberculosis","volume":"61 Suppl 3","author":"Rao","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2025111000471264000_vlaf046-B24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/mi.2011.14","article-title":"Macrophages and control of granulomatous inflammation in tuberculosis","volume":"4","author":"Flynn","year":"2011","journal-title":"Mucosal Immunol"},{"key":"2025111000471264000_vlaf046-B25","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1128\/IAI.00083-16","article-title":"Effects of B cell depletion on early Mycobacterium tuberculosis infection in cynomolgus macaques","volume":"84","author":"Phuah","year":"2016","journal-title":"Infect Immun"},{"key":"2025111000471264000_vlaf046-B26","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/s41590-023-01476-3","article-title":"Antigen-specific B cells direct T follicular-like helper cells into lymphoid follicles to mediate Mycobacterium tuberculosis control","volume":"24","author":"Swanson","year":"2023","journal-title":"Nat Immunol"},{"key":"2025111000471264000_vlaf046-B27","doi-asserted-by":"crossref","first-page":"640168","DOI":"10.3389\/fimmu.2021.640168","article-title":"B-cells and antibodies as contributors to effector immune responses in tuberculosis","volume":"12","author":"Rijnink","year":"2021","journal-title":"Front Immunol"},{"key":"2025111000471264000_vlaf046-B28","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s42003-024-06282-7","article-title":"B cell heterogeneity in human tuberculosis highlights compartment-specific phenotype and functional roles","volume":"7","author":"Krause","year":"2024","journal-title":"Commun Biol"},{"key":"2025111000471264000_vlaf046-B29","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/infdis\/jiy034","article-title":"Interleukin-21 regulates natural killer cell responses during Mycobacterium tuberculosis infection","volume":"217","author":"Paidipally","year":"2018","journal-title":"J Infect Dis"},{"key":"2025111000471264000_vlaf046-B30","doi-asserted-by":"crossref","first-page":"6639","DOI":"10.4049\/jimmunol.0902587","article-title":"IL-22 produced by human NK cells inhibits growth of Mycobacterium tuberculosis by enhancing phagolysosomal fusion","volume":"183","author":"Dhiman","year":"2009","journal-title":"J Immunol"},{"key":"2025111000471264000_vlaf046-B31","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.4049\/jimmunol.180.3.1729","article-title":"NK cells lyse T regulatory cells that expand in response to an intracellular pathogen","volume":"180","author":"Roy","year":"2008","journal-title":"J Immunol"},{"key":"2025111000471264000_vlaf046-B32","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.molcel.2018.07.009","article-title":"An antiviral branch of the IL-1 signaling pathway restricts immune-evasive virus replication","volume":"71","author":"Orzalli","year":"2018","journal-title":"Mol Cell"},{"key":"2025111000471264000_vlaf046-B33","doi-asserted-by":"crossref","first-page":"42594","DOI":"10.1074\/jbc.M111.267922","article-title":"Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36\u03b1, IL-36\u03b2, and IL-36\u03b3) or antagonist (IL-36Ra) activity","volume":"286","author":"Towne","year":"2011","journal-title":"J Biol Chem"},{"key":"2025111000471264000_vlaf046-B34","volume-title":"The practical approach series","author":"Clemens","year":"1987"},{"key":"2025111000471264000_vlaf046-B35","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/j.jaci.2018.01.001","article-title":"Ankyrin repeat domain 1 regulates innate immune responses against herpes simplex virus 1: a potential role in eczema herpeticum","volume":"141","author":"Bin","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"2025111000471264000_vlaf046-B36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cyto.2016.05.012","article-title":"Interleukin-36 potently stimulates human M2 macrophages, Langerhans cells and keratinocytes to produce pro-inflammatory cytokines","volume":"84","author":"Dietrich","year":"2016","journal-title":"Cytokine"},{"key":"2025111000471264000_vlaf046-B37","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.4049\/jimmunol.1103685","article-title":"IL-1 family members IL-18 and IL-33 upregulate the inflammatory potential of differentiated human Th1 and Th2 cultures","volume":"189","author":"Blom","year":"2012","journal-title":"J Immunol"},{"key":"2025111000471264000_vlaf046-B38","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.4049\/jimmunol.168.7.3451","article-title":"The NKp46 receptor contributes to NK cell lysis of mononuclear phagocytes infected with an intracellular bacterium","volume":"168","author":"Vankayalapati","year":"2002","journal-title":"J Immunol"},{"key":"2025111000471264000_vlaf046-B39","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4049\/jimmunol.172.1.130","article-title":"NK cells regulate CD8+ T cell effector function in response to an intracellular pathogen","volume":"172","author":"Vankayalapati","year":"2004","journal-title":"J Immunol"},{"key":"2025111000471264000_vlaf046-B40","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3892\/etm.2022.11422","article-title":"Biology of interleukin-37 and its role in autoimmune diseases (review)","volume":"24","author":"Zeng","year":"2022","journal-title":"Exp Ther Med"},{"key":"2025111000471264000_vlaf046-B41","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3390\/ijms20030649","article-title":"Interleukin-18 in health and disease","volume":"20","author":"Yasuda","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2025111000471264000_vlaf046-B42","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3389\/fimmu.2014.00491","article-title":"Macrophage cytokines: involvement in immunity and infectious diseases","volume":"5","author":"Arango Duque","year":"2014","journal-title":"Front Immunol"},{"key":"2025111000471264000_vlaf046-B43","doi-asserted-by":"crossref","first-page":"971745","DOI":"10.3389\/fendo.2022.971745","article-title":"Interleukin-18 in metabolism: from mice physiology to human diseases","volume":"13","author":"Somm","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025111000471264000_vlaf046-B44","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.3389\/fimmu.2019.02025","article-title":"The roles of IL-1 family cytokines in the pathogenesis of systemic sclerosis","volume":"10","author":"Xu","year":"2019","journal-title":"Front Immunol"},{"key":"2025111000471264000_vlaf046-B45","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1086\/315771","article-title":"Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis","volume":"182","author":"Juffermans","year":"2000","journal-title":"J Infect Dis"},{"key":"2025111000471264000_vlaf046-B46","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.4049\/jimmunol.1800438","article-title":"Cutting edge: IL-1R1 mediates host resistance to Mycobacterium tuberculosis by trans-protection of infected cells","volume":"201","author":"Bohrer","year":"2018","journal-title":"J Immunol"},{"key":"2025111000471264000_vlaf046-B47","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/mi.2011.13","article-title":"Role of innate cytokines in mycobacterial infection","volume":"4","author":"Cooper","year":"2011","journal-title":"Mucosal Immunol"},{"key":"2025111000471264000_vlaf046-B48","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/labinvest.3780079","article-title":"Protective role of interleukin-1 in mycobacterial infection in IL-1 \u03b1\/\u03b2 double-knockout mice","volume":"80","author":"Yamada","year":"2000","journal-title":"Lab Invest"},{"key":"2025111000471264000_vlaf046-B49","doi-asserted-by":"crossref","first-page":"5508","DOI":"10.4049\/jimmunol.1202121","article-title":"Cutting edge: FAS (CD95) mediates noncanonical IL-1\u03b2 and IL-18 maturation via caspase-8 in an RIP3-independent manner","volume":"189","author":"Bossaller","year":"2012","journal-title":"J Immunol"},{"key":"2025111000471264000_vlaf046-B50","doi-asserted-by":"crossref","first-page":"15942","DOI":"10.1074\/jbc.M114.557561","article-title":"Release of interleukin-1\u03b1 or interleukin-1\u03b2 depends on mechanism of cell death","volume":"289","author":"England","year":"2014","journal-title":"J Biol Chem"},{"key":"2025111000471264000_vlaf046-B51","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1073\/pnas.1324140111","article-title":"Role of caspase-1 in nuclear translocation of IL-37, release of the cytokine, and IL-37 inhibition of innate immune responses","volume":"111","author":"Bulau","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025111000471264000_vlaf046-B52","doi-asserted-by":"crossref","first-page":"696605","DOI":"10.3389\/fimmu.2021.696605","article-title":"Current understanding of IL-37 in human health and disease","volume":"12","author":"Su","year":"2021","journal-title":"Front Immunol"},{"key":"2025111000471264000_vlaf046-B53","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/eji.201848056","article-title":"Current perspectives on the interleukin-1 family as targets for inflammatory disease","volume":"49","author":"Hernandez-Santana","year":"2019","journal-title":"Eur J Immunol"},{"key":"2025111000471264000_vlaf046-B54","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.4049\/jimmunol.1202688","article-title":"IL-1\u03b2 promotes antimicrobial immunity in macrophages by regulating TNFR signaling and caspase-3 activation","volume":"190","author":"Jayaraman","year":"2013","journal-title":"J Immunol"},{"key":"2025111000471264000_vlaf046-B55","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.4049\/jimmunol.0904189","article-title":"Caspase-1 independent IL-1beta production is critical for host resistance to Mycobacterium tuberculosis and does not require TLR signaling in vivo","volume":"184","author":"Mayer-Barber","year":"2010","journal-title":"J Immunol"},{"key":"2025111000471264000_vlaf046-B56","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature13489","article-title":"Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk","volume":"511","author":"Mayer-Barber","year":"2014","journal-title":"Nature"},{"key":"2025111000471264000_vlaf046-B57","doi-asserted-by":"crossref","first-page":"e40722","DOI":"10.1371\/journal.pone.0040722","article-title":"Mycobacterium tuberculosis infection of dendritic cells leads to partially caspase-1\/11-independent IL-1\u03b2 and IL-18 secretion but not to pyroptosis","volume":"7","author":"Abdalla","year":"2012","journal-title":"PLoS One"},{"key":"2025111000471264000_vlaf046-B58","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/eji.200939583","article-title":"A role for IL-18 in protective immunity against Mycobacterium tuberculosis","volume":"40","author":"Schneider","year":"2010","journal-title":"Eur J Immunol"},{"key":"2025111000471264000_vlaf046-B59","doi-asserted-by":"crossref","first-page":"41240","DOI":"10.1038\/srep41240","article-title":"M2 macrophages or IL-33 treatment attenuate ongoing Mycobacterium tuberculosis infection","volume":"7","author":"Pi\u00f1eros","year":"2017","journal-title":"Sci Rep"},{"key":"2025111000471264000_vlaf046-B60","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/infdis\/jiw152","article-title":"Role of interleukin 36\u03b3 in host defense against tuberculosis","volume":"214","author":"Ahsan","year":"2016","journal-title":"J Infect Dis"},{"key":"2025111000471264000_vlaf046-B61","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1038\/s41598-018-19476-x","article-title":"IL-36\/LXR axis modulates cholesterol metabolism and immune defense to Mycobacterium tuberculosis","volume":"8","author":"Ahsan","year":"2018","journal-title":"Sci Rep"},{"key":"2025111000471264000_vlaf046-B62","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/sji.12326","article-title":"IL-37 expression is upregulated in patients with tuberculosis and induces macrophages towards an M2-like phenotype","volume":"82","author":"Huang","year":"2015","journal-title":"Scand J Immunol"},{"key":"2025111000471264000_vlaf046-B63","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s12026-022-09275-y","article-title":"An overview of the biological and multifunctional roles of IL-38 in different infectious diseases and COVID-19","volume":"70","author":"Fazeli","year":"2022","journal-title":"Immunol Res"},{"key":"2025111000471264000_vlaf046-B64","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.imlet.2018.05.003","article-title":"Deficiency of IL-1 receptor antagonist suppresses IL-10-producing B cells in autoimmune arthritis in an IL-17\/Th17-dependent manner","volume":"199","author":"Park","year":"2018","journal-title":"Immunol Lett"},{"key":"2025111000471264000_vlaf046-B65","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4049\/jimmunol.132.1.223","article-title":"Interleukin 1-mediated induction of kappa-light chain synthesis and surface immunoglobulin expression on pre-B cells","volume":"132","author":"Giri","year":"1984","journal-title":"J Immunol"},{"key":"2025111000471264000_vlaf046-B66","doi-asserted-by":"crossref","first-page":"110728","DOI":"10.1016\/j.celrep.2022.110728","article-title":"Human IL-10-producing B cells have diverse states that are induced from multiple B cell subsets","volume":"39","author":"Glass","year":"2022","journal-title":"Cell Rep"},{"key":"2025111000471264000_vlaf046-B67","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/978-1-4614-6111-1_12","article-title":"The role of B cells and humoral immunity in Mycobacterium tuberculosis infection","volume":"783","author":"Kozakiewicz","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"2025111000471264000_vlaf046-B68","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40249-015-0046-0","article-title":"Profiling B and T cell immune responses to co-infection of Mycobacterium tuberculosis and hookworm in humans","volume":"4","author":"Li","year":"2015","journal-title":"Infect Dis Poverty"},{"key":"2025111000471264000_vlaf046-B69","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/imr.12276","article-title":"B cells and antibodies in the defense against Mycobacterium tuberculosis infection","volume":"264","author":"Achkar","year":"2015","journal-title":"Immunol Rev"},{"key":"2025111000471264000_vlaf046-B70","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1134\/S0006297914120098","article-title":"Formation of compact aggregates of B-lymphocytes in lung tissue during mycobacterial infection in mice depends on TNF production by these cells and is not an element of the host\u2019s immunological protection","volume":"79","author":"Kondratieva","year":"2014","journal-title":"Biochemistry (Mosc)"},{"key":"2025111000471264000_vlaf046-B71","doi-asserted-by":"crossref","first-page":"e106796","DOI":"10.1371\/journal.pone.0106796","article-title":"Circulating B-lymphocytes as potential biomarkers of tuberculosis infection activity","volume":"9","author":"Sebina","year":"2014","journal-title":"PLoS One"},{"key":"2025111000471264000_vlaf046-B72","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.diagmicrobio.2013.12.018","article-title":"Utility of B-cell epitopes based peptides of RD1 and RD2 antigens for immunodiagnosis of pulmonary tuberculosis","volume":"78","author":"Goyal","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2025111000471264000_vlaf046-B73","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3389\/fimmu.2020.00891","article-title":"Evaluation of IL-1 blockade as an adjunct to linezolid therapy for tuberculosis in mice and macaques","volume":"11","author":"Winchell","year":"2020","journal-title":"Front Immunol"},{"key":"2025111000471264000_vlaf046-B74","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3389\/fimmu.2018.00835","article-title":"Targeting B cells and plasma cells in autoimmune diseases","volume":"9","author":"Hofmann","year":"2018","journal-title":"Front Immunol"},{"key":"2025111000471264000_vlaf046-B75","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.4049\/jimmunol.181.8.5545","article-title":"Interleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA\/J mice","volume":"181","author":"Beamer","year":"2008","journal-title":"J Immunol"},{"key":"2025111000471264000_vlaf046-B76","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/intimm\/dxv026","article-title":"Regulatory B cells in human inflammatory and autoimmune diseases: from mouse models to clinical research","volume":"27","author":"Miyagaki","year":"2015","journal-title":"Int Immunol"},{"key":"2025111000471264000_vlaf046-B77","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2147\/JIR.S286426","article-title":"The role of regulatory B cells in health and diseases: a systemic review","volume":"14","author":"Chekol Abebe","year":"2021","journal-title":"J Inflamm Res"},{"key":"2025111000471264000_vlaf046-B78","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1172\/JCI119488","article-title":"Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein","volume":"99","author":"Gabay","year":"1997","journal-title":"J Clin Invest"},{"key":"2025111000471264000_vlaf046-B79","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.4049\/jimmunol.149.6.2000","article-title":"Human IL-1 receptor antagonist promoter. Cell type\u2013specific activity and identification of regulatory regions","volume":"149","author":"Smith","year":"1992","journal-title":"J Immunol"},{"key":"2025111000471264000_vlaf046-B80","doi-asserted-by":"crossref","first-page":"111783","DOI":"10.1016\/j.celrep.2022.111783","article-title":"Mucosal exposure to non-tuberculous mycobacteria elicits B cell-mediated immunity against pulmonary tuberculosis","volume":"41","author":"Dutt","year":"2022","journal-title":"Cell Rep"},{"key":"2025111000471264000_vlaf046-B81","doi-asserted-by":"crossref","first-page":"7222","DOI":"10.4049\/jimmunol.178.11.7222","article-title":"B cells moderate inflammatory progression and enhance bacterial containment upon pulmonary challenge with Mycobacterium tuberculosis","volume":"178","author":"Maglione","year":"2007","journal-title":"J Immunol"},{"key":"2025111000471264000_vlaf046-B82","doi-asserted-by":"crossref","first-page":"114426","DOI":"10.1016\/j.celrep.2024.114426","article-title":"Splenic marginal zone B cells restrict Mycobacterium tuberculosis infection by shaping the cytokine pattern and cell-mediated immunity","volume":"43","author":"Tsai","year":"2024","journal-title":"Cell Rep"},{"key":"2025111000471264000_vlaf046-B83","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2215\/CJN.09430915","article-title":"B cells, antibodies, and more","volume":"11","author":"Hoffman","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025111000471264000_vlaf046-B84","doi-asserted-by":"crossref","first-page":"830482","DOI":"10.3389\/fimmu.2022.830482","article-title":"Leveraging antibody, B cell and Fc receptor interactions to understand heterogeneous immune responses in tuberculosis","volume":"13","author":"Carpenter","year":"2022","journal-title":"Front Immunol"}],"container-title":["ImmunoHorizons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/immunohorizons\/article-pdf\/9\/11\/vlaf046\/65249739\/vlaf046.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/immunohorizons\/article-pdf\/9\/11\/vlaf046\/65249739\/vlaf046.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T05:47:29Z","timestamp":1762753649000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/immunohorizons\/article\/doi\/10.1093\/immhor\/vlaf046\/8317565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":84,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11,9]]}},"URL":"https:\/\/doi.org\/10.1093\/immhor\/vlaf046","relation":{},"ISSN":["2573-7732"],"issn-type":[{"value":"2573-7732","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,10,9]]},"article-number":"vlaf046"}}